{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T19:51:37Z","timestamp":1782417097280,"version":"3.54.5"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2017,1,12]],"date-time":"2017-01-12T00:00:00Z","timestamp":1484179200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100004334","name":"Merck","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004334","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur Radiol"],"published-print":{"date-parts":[[2017,8]]},"DOI":"10.1007\/s00330-016-4717-4","type":"journal-article","created":{"date-parts":[[2017,1,12]],"date-time":"2017-01-12T04:55:09Z","timestamp":1484196909000},"page":"3275-3282","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":40,"title":["Serial assessment of pulmonary lesion volume by computed tomography allows survival prediction in invasive pulmonary aspergillosis"],"prefix":"10.1007","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5446-7170","authenticated-orcid":false,"given":"J. J.","family":"Vehreschild","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. P.","family":"Heussel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. H.","family":"Groll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. J. G. T.","family":"Vehreschild","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Silling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"W\u00fcrthwein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Brecht","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O. A.","family":"Cornely","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,1,12]]},"reference":[{"key":"4717_CR1","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1097\/00005792-200007000-00006","volume":"79","author":"TF Patterson","year":"2000","unstructured":"Patterson TF, Kirkpatrick WR, White M et al (2000) Invasive aspergillosis. Disease spectrum, treatment practices, and outcomes. I3 Aspergillus Study Group. Medicine (Baltimore) 79:250\u2013260","journal-title":"Medicine (Baltimore)"},{"key":"4717_CR2","doi-asserted-by":"crossref","first-page":"345","DOI":"10.7326\/0003-4819-100-3-345","volume":"100","author":"SL Gerson","year":"1984","unstructured":"Gerson SL, Talbot GH, Hurwitz S, Strom BL, Lusk EJ, Cassileth PA (1984) Prolonged granulocytopenia: the major risk factor for invasive pulmonary aspergillosis in patients with acute leukemia. Ann Intern Med 100:345\u2013351","journal-title":"Ann Intern Med"},{"key":"4717_CR3","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1086\/651263","volume":"50","author":"DP Kontoyiannis","year":"2010","unstructured":"Kontoyiannis DP, Marr KA, Park BJ et al (2010) Prospective surveillance for invasive fungal infections in hematopoietic stem cell transplant recipients, 2001-2006: overview of the Transplant-Associated Infection Surveillance Network (TRANSNET) Database. Clin Infect Dis 50:1091\u20131100","journal-title":"Clin Infect Dis"},{"key":"4717_CR4","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.2214\/ajr.169.5.9353456","volume":"169","author":"CP Heussel","year":"1997","unstructured":"Heussel CP, Kauczor HU, Heussel G, Fischer B, Mildenberger P, Thelen M (1997) Early detection of pneumonia in febrile neutropenic patients: use of thin-section CT. AJR Am J Roentgenol 169:1347\u20131353","journal-title":"AJR Am J Roentgenol"},{"key":"4717_CR5","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1200\/JCO.1999.17.3.796","volume":"17","author":"CP Heussel","year":"1999","unstructured":"Heussel CP, Kauczor HU, Heussel GE et al (1999) Pneumonia in febrile neutropenic patients and in bone marrow and blood stem-cell transplant recipients: use of high-resolution computed tomography. J Clin Oncol 17:796\u2013805","journal-title":"J Clin Oncol"},{"key":"4717_CR6","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1056\/NEJMoa020191","volume":"347","author":"R Herbrecht","year":"2002","unstructured":"Herbrecht R, Denning DW, Patterson TF et al (2002) Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis. N Engl J Med 347:408\u2013415","journal-title":"N Engl J Med"},{"key":"4717_CR7","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1086\/514341","volume":"44","author":"OA Cornely","year":"2007","unstructured":"Cornely OA, Maertens J, Bresnik M et al (2007) Liposomal amphotericin B as initial therapy for invasive mold infection: a randomized trial comparing a high-loading dose regimen with standard dosing (AmBiLoad trial). Clin Infect Dis 44:1289\u20131297","journal-title":"Clin Infect Dis"},{"key":"4717_CR8","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.2165\/00003495-200868140-00002","volume":"68","author":"MJ Ruping","year":"2008","unstructured":"Ruping MJ, Vehreschild JJ, Cornely OA (2008) Patients at high risk of invasive fungal infections: when and how to treat. Drugs 68:1941\u20131962","journal-title":"Drugs"},{"key":"4717_CR9","doi-asserted-by":"crossref","first-page":"e557","DOI":"10.1111\/j.1439-0507.2010.01989.x","volume":"54","author":"MJ Ruping","year":"2011","unstructured":"Ruping MJ, Vehreschild JJ, Groll A et al (2011) Current issues in the clinical management of invasive aspergillosis--the AGIHO, DMykG, OGMM and PEG web-based survey and expert consensus conference 2009. Mycoses 54:e557\u2013e568","journal-title":"Mycoses"},{"key":"4717_CR10","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1128\/JCM.02281-09","volume":"48","author":"S Koo","year":"2010","unstructured":"Koo S, Bryar JM, Baden LR, Marty FM (2010) Prognostic features of galactomannan antigenemia in galactomannan-positive invasive aspergillosis. J Clin Microbiol 48:1255\u20131260","journal-title":"J Clin Microbiol"},{"key":"4717_CR11","doi-asserted-by":"crossref","first-page":"2330","DOI":"10.1128\/JCM.06513-11","volume":"50","author":"LYA Chai","year":"2012","unstructured":"Chai LYA, Kullberg BJ, Johnson EM et al (2012) Early serum galactomannan trend as a predictor of outcome of invasive aspergillosis. J Clin Microbiol 50:2330\u20132336","journal-title":"J Clin Microbiol"},{"key":"4717_CR12","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1002\/cncr.22863","volume":"110","author":"G Woods","year":"2007","unstructured":"Woods G, Miceli MH, Grazziutti ML, Zhao WZ, Barlogie B, Anaissie E (2007) Serum aspergillus galactomannan antigen values strongly correlate with outcome of invasive aspergillosis - a study of 56 patients with hematologic cancer. Cancer 110:830\u2013834","journal-title":"Cancer"},{"key":"4717_CR13","doi-asserted-by":"crossref","first-page":"E173","DOI":"10.1016\/j.ejrad.2009.05.058","volume":"74","author":"D Caillot","year":"2010","unstructured":"Caillot D, Latrabe V, Thiebaut A et al (2010) Computer tomography in pulmonary invasive aspergillosis in hematological patients with neutropenia: an useful tool for diagnosis and assessment of outcome in clinical trials. Eur J Radiol 74:E173\u2013E176","journal-title":"Eur J Radiol"},{"key":"4717_CR14","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1016\/j.crad.2012.02.018","volume":"67","author":"C Lim","year":"2012","unstructured":"Lim C, Seo JB, Park SY et al (2012) Analysis of initial and follow-up CT findings in patients with invasive pulmonary aspergillosis after solid organ transplantation. Clin Radiol 67:1179\u20131186","journal-title":"Clin Radiol"},{"key":"4717_CR15","doi-asserted-by":"crossref","first-page":"404","DOI":"10.2214\/AJR.05.0513","volume":"187","author":"H Brodoefel","year":"2006","unstructured":"Brodoefel H, Vogel M, Hebart H et al (2006) Long-term CT follow-up in 40 non-HIV immunocompromised patients with invasive pulmonary aspergillosis: kinetics of CT morphology and correlation with clinical findings and outcome. Am J Roentgenol 187:404\u2013413","journal-title":"Am J Roentgenol"},{"key":"4717_CR16","first-page":"S218","volume":"45","author":"O Cornely","year":"2010","unstructured":"Cornely O, Vehreschild JJ, Ruping M et al (2010) A phase II dose escalation study of caspofungin for invasive aspergillosis. Bone Marrow Transplant 45:S218\u2013S219","journal-title":"Bone Marrow Transplant"},{"key":"4717_CR17","doi-asserted-by":"crossref","first-page":"5798","DOI":"10.1128\/AAC.05134-11","volume":"55","author":"OA Cornely","year":"2011","unstructured":"Cornely OA, Vehreschild JJ, Vehreschild MJ et al (2011) Phase II dose escalation study of caspofungin for invasive Aspergillosis. Antimicrob Agents Chemother 55:5798\u20135803","journal-title":"Antimicrob Agents Chemother"},{"key":"4717_CR18","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1128\/AAC.01912-12","volume":"57","author":"G Wurthwein","year":"2013","unstructured":"Wurthwein G, Cornely OA, Trame MN et al (2013) Population pharmacokinetics of escalating doses of caspofungin in a phase II study of patients with invasive aspergillosis. Antimicrob Agents Chemother 57:1664\u20131671","journal-title":"Antimicrob Agents Chemother"},{"key":"4717_CR19","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1086\/588660","volume":"46","author":"B Pauw De","year":"2008","unstructured":"De Pauw B, Walsh TJ, Donnelly JP et al (2008) Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer\/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC\/MSG) Consensus Group. Clin Infect Dis 46:1813\u20131821","journal-title":"Clin Infect Dis"},{"key":"4717_CR20","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1086\/509917","volume":"44","author":"RE Greene","year":"2007","unstructured":"Greene RE, Schlamm HT, Oestmann JW et al (2007) Imaging findings in acute invasive pulmonary aspergillosis: clinical significance of the halo sign. Clin Infect Dis 44:373\u2013379","journal-title":"Clin Infect Dis"},{"key":"4717_CR21","doi-asserted-by":"crossref","first-page":"e449","DOI":"10.1111\/j.1439-0507.2010.01947.x","volume":"54","author":"OA Cornely","year":"2011","unstructured":"Cornely OA, Maertens J, Bresnik M et al (2011) Efficacy outcomes in a randomised trial of liposomal amphotericin B based on revised EORTC\/MSG 2008 definitions of invasive mould disease. Mycoses 54:e449\u2013e455","journal-title":"Mycoses"},{"key":"4717_CR22","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1038\/bmt.2011.154","volume":"47","author":"L Castagna","year":"2012","unstructured":"Castagna L, Bramanti S, Sarina B, Todisco E, Ibatici A, Santoro A (2012) ECIL 3-2009 update guidelines for antifungal management. Bone Marrow Transplant 47:866","journal-title":"Bone Marrow Transplant"},{"key":"4717_CR23","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1038\/bmt.2010.175","volume":"46","author":"J Maertens","year":"2011","unstructured":"Maertens J, Marchetti O, Herbrecht R et al (2011) European guidelines for antifungal management in leukemia and hematopoietic stem cell transplant recipients: summary of the ECIL 3\u20132009 update. Bone Marrow Transplant 46:709\u2013718","journal-title":"Bone Marrow Transplant"},{"key":"4717_CR24","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1093\/jac\/dku009","volume":"69","author":"J Fischer","year":"2014","unstructured":"Fischer J, van Koningsbruggen-Rietschel S, Rietschel E et al (2014) Prevalence and molecular characterization of azole resistance in Aspergillus spp. isolates from German cystic fibrosis patients. J Antimicrob Chemother 69:1533\u20131536","journal-title":"J Antimicrob Chemother"},{"key":"4717_CR25","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1093\/jac\/dku566","volume":"70","author":"J Steinmann","year":"2015","unstructured":"Steinmann J, Hamprecht A, Vehreschild MJ et al (2015) Emergence of azole-resistant invasive aspergillosis in HSCT recipients in Germany. J Antimicrob Chemother 70:1522\u20131526","journal-title":"J Antimicrob Chemother"},{"key":"4717_CR26","doi-asserted-by":"crossref","first-page":"e101","DOI":"10.1086\/521245","volume":"45","author":"C Lass-Florl","year":"2007","unstructured":"Lass-Florl C, Resch G, Nachbaur D et al (2007) The value of computed tomography-guided percutaneous lung biopsy for diagnosis of invasive fungal infection in immunocompromised patients. Clin Infect Dis 45:e101\u2013e104","journal-title":"Clin Infect Dis"},{"key":"4717_CR27","first-page":"528","volume":"87","author":"M Subira","year":"2002","unstructured":"Subira M, Martino R, Franquet T et al (2002) Invasive pulmonary aspergillosis in patients with hematologic malignancies: survival and prognostic factors. Haematologica 87:528\u2013534","journal-title":"Haematologica"},{"key":"4717_CR28","doi-asserted-by":"crossref","first-page":"644","DOI":"10.3324\/haematol.2009.012054","volume":"95","author":"L Pagano","year":"2010","unstructured":"Pagano L, Caira M, Candoni A et al (2010) Invasive aspergillosis in patients with acute myeloid leukemia: a SEIFEM-2008 registry study. Haematol Hematol J 95:644\u2013650","journal-title":"Haematol Hematol J"}],"container-title":["European Radiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00330-016-4717-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00330-016-4717-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00330-016-4717-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,29]],"date-time":"2017-06-29T08:14:10Z","timestamp":1498724050000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00330-016-4717-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1,12]]},"references-count":28,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2017,8]]}},"alternative-id":["4717"],"URL":"https:\/\/doi.org\/10.1007\/s00330-016-4717-4","relation":{},"ISSN":["0938-7994","1432-1084"],"issn-type":[{"value":"0938-7994","type":"print"},{"value":"1432-1084","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,1,12]]}}}